Literature DB >> 15277345

Biopsy or biomarkers: is there a gold standard for diagnosis of liver fibrosis?

Nezam H Afdhal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15277345     DOI： 10.1373/clinchem.2004.035899

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  22 in total

1.  Noninvasive assessment of liver fibrosis using ultrasound-based shear wave measurement and comparison to magnetic resonance elastography.

Authors:  Heng Zhao; Jun Chen; Duane D Meixner; Hua Xie; Vijay Shamdasani; Shiwei Zhou; Jean-Luc Robert; Matthew W Urban; William Sanchez; Matthew R Callstrom; Richard L Ehman; James F Greenleaf; Shigao Chen
Journal:  J Ultrasound Med       Date:  2014-09       Impact factor: 2.153

2.  Metrically measuring liver biopsy: a chronic hepatitis B and C computer-aided morphologic description.

Authors:  Nicola Dioguardi; Fabio Grizzi; Barbara Fiamengo; Carlo Russo
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

3.  Sampling variability of computer-aided fractal-corrected measures of liver fibrosis in needle biopsy specimens.

Authors:  Fabio Grizzi; Carlo Russo; Barbara Franceschini; Mariagrazia Di Rocco; Valter Torri; Emanuela Morenghi; Luigi Rainiero Fassati; Nicola Dioguardi
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

4.  Noninvasive Markers of Liver Fibrosis.

Authors:  Nezam H Afdhal
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-06

5.  Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha.

Authors:  Dariusz-Marek Lebensztejn; Maria-Elzbieta Sobaniec-Lotowska; Maciej Kaczmarski; Michael Voelker; Detlef Schuppan
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

Review 6.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

7.  Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population.

Authors:  Hui-Chen Wu; Hwai-I Yang; Qiao Wang; Chien-Jen Chen; Regina M Santella
Journal:  Carcinogenesis       Date:  2017-10-01       Impact factor: 4.944

8.  Evaluation of Histological and non-Invasive Methods for the Detection of Liver Fibrosis: The Values of Histological and Digital Morphometric Analysis, Liver Stiffness Measurement and APRI Score.

Authors:  Tünde Halász; Gábor Horváth; András Kiss; Gabriella Pár; Andrea Szombati; Fanni Gelley; Balázs Nemes; István Kenessey; Violetta Piurkó; Zsuzsa Schaff
Journal:  Pathol Oncol Res       Date:  2015-07-19       Impact factor: 3.201

9.  Serum prolidase and IGF-1 as non-invasive markers of hepatic fibrosis during four different periods after bile-duct ligation in rats.

Authors:  Orhan Tarçin; Nursal Gedik; Berna Karakoyun; Veysel Tahan; Gagan Sood; Ciğdem Celikel; Nurdan Tözün
Journal:  Dig Dis Sci       Date:  2007-11-13       Impact factor: 3.199

10.  Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat.

Authors:  Meng Fang; Sylviane Dewaele; Yun-Peng Zhao; Peter Stärkel; Valerie Vanhooren; Yue-Ming Chen; Xin Ji; Ming Luo; Bao-Mu Sun; Yves Horsmans; Anne Dell; Stuart M Haslam; Paola Grassi; Claude Libert; Chun-Fang Gao; Cuiying Chitty Chen
Journal:  Mol Cancer       Date:  2010-08-12       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.